Cargando…

Autoantibody Biomarkers in Rheumatic Diseases

Autoantibodies encountered in patients with systemic rheumatic diseases bear clinical significance as a biomarker to help or predict diagnosis, clinical phenotypes, prognosis, and treatment decision-making. Furthermore, evidence has accumulated regarding the active involvement of disease-specific or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Eun Ha, Ha, You-Jung, Lee, Yun Jong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073052/ https://www.ncbi.nlm.nih.gov/pubmed/32085664 http://dx.doi.org/10.3390/ijms21041382

Ejemplares similares

Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment
por: Ha, You-Jung, et al.
Publicado: (2018)

Emerging technologies in autoantibody testing for rheumatic diseases
por: Olsen, Nancy J., et al.
Publicado: (2017)

Pharmacological Interventions for Pulmonary Involvement in Rheumatic Diseases
por: Kang, Eun Ha, et al.
Publicado: (2021)

From rheumatic diseases to cancer - role of autoantibodies as diagnostic biomarkers
por: Tan, Eng M
Publicado: (2012)

Autoantibody Profiles in Autoimmune Rheumatic Diseases
por: Bizzaro, Nicola
Publicado: (2019)

Performance of the 2015 American College of Rheumatology/European League against Rheumatism Classification Criteria for Gout in Korean Patients with Acute Arthritis
por: Choi, In Ah, et al.
Publicado: (2019)

Role of Natural Autoantibodies in Ugandans With Rheumatic Heart Disease and HIV()
por: Huck, Daniel M., et al.
Publicado: (2016)

Ultrasound as a Biomarker in Rheumatic Diseases
por: Quin, Kai, et al.
Publicado: (2020)

Impact of early age at menopause on disease outcomes in postmenopausal women with rheumatoid arthritis: a large observational cohort study of Korean patients with rheumatoid arthritis
por: Park, Eun Hye, et al.
Publicado: (2023)

Mapping Autoantibodies in Children With Acute Rheumatic Fever
por: McGregor, Reuben, et al.
Publicado: (2021)

The Uses and Misuses of Multiplex Autoantibody Assays in Systemic Autoimmune Rheumatic Diseases
por: Satoh, Minoru, et al.
Publicado: (2015)

SEROLOGICAL STUDIES IN RHEUMATIC FEVER : I. THE "PHASE" REACTION AND THE DETECTION OF AUTOANTIBODIES IN THE RHEUMATIC STATE
por: Fischel, Edward E., et al.
Publicado: (1949)

Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease
por: Lee, Jeong Seok, et al.
Publicado: (2019)

Tumor-associated autoantibodies as diagnostic and prognostic biomarkers
por: Heo, Chang-Kyu, et al.
Publicado: (2012)

Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
por: Kang, Eun Ha, et al.
Publicado: (2010)

Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases
por: Kocurova, Gabriela, et al.
Publicado: (2022)

Interleukin-13 (IL-13)in autoimmune rheumatic diseases: relationship with autoantibody profile
por: Rinaldi, T, et al.
Publicado: (2001)

Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders
por: Kuwana, Masataka, et al.
Publicado: (2021)

Association Between Rheumatic Autoantibodies and Immune-Related Adverse Events
por: Mathias, Kristen, et al.
Publicado: (2023)

Autoantibodies as Potential Biomarkers in Breast Cancer
por: Qiu, Jingyi, et al.
Publicado: (2018)

Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
por: Yoshifuji, Hajime
Publicado: (2016)

Prevalence of thyroid autoantibodies in patients with systematic autoimmune rheumatic diseases. Cross-sectional study
por: Posselt, Rayana Taques, et al.
Publicado: (2017)

Designing Studies for Epigenetic Biomarker Development in Autoimmune Rheumatic Diseases
por: de la Calle-Fabregat, Carlos, et al.
Publicado: (2022)

A Case of Macrophage Activation Syndrome During the Treatment of Adult-onset Still’s Disease With Tocilizumab
por: Lee, Ju Ho, et al.
Publicado: (2022)

What about rheumatic diseases and COVID-19?
por: Aouissi, H.A., et al.
Publicado: (2021)

Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data
por: Yoo, Wan-Hee, et al.
Publicado: (2022)

Assessment on Treatments With Conventional Synthetic Disease-modifying Drugs Before Initiating Biologics in Patients With Rheumatoid Arthritis in Korea: A Population-based Study
por: Kim, Min Jung, et al.
Publicado: (2022)

Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
por: Graßhoff, Hanna, et al.
Publicado: (2022)

Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases
por: Scrivo, Rossana, et al.
Publicado: (2013)

Is there a potential of circulating miRNAs as biomarkers in rheumatic diseases?
por: Prajzlerová, Klára, et al.
Publicado: (2022)

The Extent and Diverse Trajectories of Longitudinal Changes in Rheumatoid Arthritis Interstitial Lung Diseases Using Quantitative HRCT Scores
por: Lee, Jeong Seok, et al.
Publicado: (2021)

The Rheumatic Diseases
Publicado: (1950)

The Rheumatic Diseases
Publicado: (1945)

Recurrent focal myofasciitis of Behçet syndrome mimics infectious myofasciitis: a case report
por: Chung, Sang Wan, et al.
Publicado: (2023)

Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study
por: Choi, Se Rim, et al.
Publicado: (2023)

Three Cases of Spondyloepiphyseal Dysplasia Tarda in One Korean Family
por: Chung, Sang Wan, et al.
Publicado: (2016)

Association of rheumatoid arthritis and high sodium intake with major adverse cardiovascular events: a cross-sectional study from the seventh Korean National Health and Nutrition Examination Survey
por: Bae, Jeong-Hyeon, et al.
Publicado: (2021)

The Spectrum of Anti-Chromatin/Nucleosome Autoantibodies: Independent and Interdependent Biomarkers of Disease
por: Mehra, Sonal, et al.
Publicado: (2014)

Autoantibodies in Alzheimer’s disease: potential biomarkers, pathogenic roles, and therapeutic implications
por: Wu, Jianming, et al.
Publicado: (2016)

Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic
por: Seo, Mi Ryoung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q3isn1uhf7rljpbv17g56j2g19